Disease-free survival (A) in all patients (N = 184) and (B) according to stages.

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survival (C).

Kiyoaki Tsukahara (691531)
Akira Kubota (691532)
Yasuhisa Hasegawa (691533)
Hideki Takemura (691534)
Tomonori Terada (691535)
Takahide Taguchi (691536)
Kunihiko Nagahara (691537)
Hiroaki Nakatani (691538)
Kunitoshi Yoshino (691539)
Yuichiro Higaki (691540)
Shigemichi Iwae (691541)
Takeshi Beppu (691542)
Yutaka Hanamure (691543)
Kichinobu Tomita (691544)
Naoyuki Kohno (691545)
Kazuyoshi Kawabata (691546)
Masanori Fukushima (457544)
Satoshi Teramukai (386488)
Masato Fujii (691547)

February 2015

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survi...

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.

Taeryool Koo (797686)
Changhoon Song (728439)
Jae-Sung Kim (605888)
Kyubo Kim (311503)
Eui Kyu Chie (73314)
Sung-Bum Kang (538677)
Keun-Wook Lee (403308)
Jee Hyun Kim (77143)
Seung-Yong Jeong (414029)
Tae-You Kim (73316)

September 2015

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.</p

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.

Federica Pedica (432701)
Andrea Ruzzenente (432702)
Fabio Bagante (432703)
Paola Capelli (432704)
Ivana Cataldo (432705)
Serena Pedron (295544)
Calogero Iacono (432706)
Marco Chilosi (295554)
Aldo Scarpa (242345)
Matteo Brunelli (295531)
Anna Tomezzoli (432707)
Guido Martignoni (295553)
Alfredo Guglielmi (432708)

July 2013

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.</p

Disease-free survival of the patients by three risk groups according to the predicted risk probability.

Hye-Jin Shin (508261)
Jungnam Joo (29049)
Ji Hyun Yoon (508264)
Chong Woo Yoo (508265)
Joo-Young Kim (235999)

January 2014

Disease-free survival of the patients by three risk groups according to the predicted risk probab...

Progression-free survival A) in all, B) in patients stratified by non-responders and responders, and overall survival C) in all, D) in patients stratified by non-responders and responders.

Shih-Hsin Hsiao (106194)
H. Eugene Liu (501592)
Hsin-Lun Lee (501593)
Chii-Lan Lin (501594)
Wei-Yu Chen (316810)
Zhung-Han Wu (501595)
Sey-En Lin (382444)
Ling-Ling Chiang (501596)
Chi-Li Chung (106193)

December 2013

Progression-free survival A) in all, B) in patients stratified by non-responders and responders, ...

Progression-free survival in relation to clinical-pathological characteristics of patients.

Andrea Casadei Gardini (509580)
Laura Capelli (509585)
Paola Ulivi (11121)
Massimo Giannini (538695)
Eva Freier (538696)
Stefano Tamberi (538697)
Emanuela Scarpi (382324)
Alassandro Passardi (538698)
Wainer Zoli (11120)
Angela Ragazzini (538699)
Dino Amadori (11130)
Giovanni Luca Frassineti (16187)

March 2014

Progression-free survival in relation to clinical-pathological characteristics of patients.</p

Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.

Imran Ahmad (5655154)
Gabriela Kalna (192504)
Mohamed Ismail (349568)
Fiona Birrell (443781)
Sue Asterling (443782)
Elaine McCartney (443783)
Damien Greene (443784)
John Davies (78364)
Hing Y. Leung (152252)

August 2013

Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.</p

Disease-free survival by treatment (chemoradiation therapy or radiation therapy alone).

David T. Miyamoto (419629)
Akila N. Viswanathan (419630)

June 2013

Disease-free survival by treatment (chemoradiation therapy or radiation therapy alone).</p

Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group in the whole group of patients.

Peng Zhang (2071)
Mian Xi (416661)
Lei Zhao (144153)
Jing-Xian Shen (498900)
Qiao-Qiao Li (416662)
Li-Ru He (617087)
Shi-Liang Liu (498899)
Meng-Zhong Liu (416667)

August 2014

Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group ...

Overall survival and disease-free survival of patients in the primary NACT group by the number of lymph nodes involved (A, B) and the number of lymph node groups involved (C, D).

Ting Hu (110925)
Xiong Li (112522)
Qinghua Zhang (145923)
Kecheng Huang (636531)
Yao Jia (429494)
Ru Yang (429495)
Fangxu Tang (720336)
Qiang Tian (46635)
Ding Ma (115288)
Shuang Li (146392)

April 2015

Overall survival and disease-free survival of patients in the primary NACT group by the number of...

Survival outcomes.

Yuri Jeong (781386)
Sang Min Yoon (481489)
Seungbong Han (781387)
Ju Hyun Shim (481492)
Kang Mo Kim (154235)
Young-Suk Lim (388118)
Han Chu Lee (154230)
So Yeon Kim (196803)
Jin-hong Park (481496)
Sang-wook Lee (3358886)
Seung Do Ahn (781388)
Eun Kyung Choi (781389)
Jong Hoon Kim (481497)

August 2015

Overall survival rates (A) and progression-free survival rates (B) in all patients.</p

A. Disease-free survival according to treatment group. Fig 1A shows Kaplan Meier’s disease-free survival curves according to treatment group. B. Disease-free survival according to stage. Fig 1B shows Kaplan Meier’s disease-free survival curves according to stage; the analysis was performed on 301 patients, since data on stage were missing for 2 patients.

Stefania Gori (591005)
Alessandro Inno (792326)
Elena Fiorio (792327)
Jennifer Foglietta (792328)
Antonella Ferro (792329)
Marcella Gulisano (792330)
Graziella Pinotti (792331)
Marta Gubiotti (792332)
Maria Giovanna Cavazzini (792333)
Monica Turazza (792334)
Simona Duranti (792335)
Valeria De Simone (792336)
Laura Iezzi (792337)
Giancarlo Bisagni (792338)
Simon Spazzapan (792339)
Luigi Cavanna (780317)
Chiara Saggia (792340)
Emilio Bria (295532)
Elisabetta Cretella (792341)
Patrizia Vici (85361)
Daniele Santini (222870)
Alessandra Fabi (85359)
Ornella Garrone (792342)
Antonio Frassoldati (792343)
Laura Amaducci (792344)
Silvana Saracchini (792345)
Lucia Evangelisti (792346)
Sandro Barni (477365)
Teresa Gamucci (477362)
Lucia Mentuccia (792347)
Lucio Laudadio (792348)
Alessandra Zoboli (792349)
Fabiana Marchetti (792350)
Giuseppe Bogina (792351)
Gianluigi Lunardi (792352)
Luca Boni (102949)

September 2015

A. Disease-free survival according to treatment group. Fig 1A shows Kaplan Meier’s disease-free s...

Overall survival and disease-free survival according to cut-off value 3 of pre-NLR (A, B) and post-NLR (C, D).

Yoon Jin Cha (603666)
Eun Jung Park (257700)
Seung Hyuk Baik (6078800)
Kang Young Lee (4524670)
Jeonghyun Kang (6078797)

March 2019

Overall survival and disease-free survival according to cut-off value 3 of pre-NLR (A, B) and post-N...

Progression Free Survival (PFS) according to stage (localized or metastatic disease).

Maria Antonietta De Ioris (285547)
Arcangelo Prete (285549)
Raffaele Cozza (285551)
Marta Podda (285554)
Carla Manzitti (285556)
Andrea Pession (229860)
Elisabetta Schiavello (285558)
Benedetta Contoli (285560)
Rita Balter (104350)
Franca Fagioli (285563)
Gianni Bisogno (285565)
Loredana Amoroso (285567)
Franco Locatelli (130400)
Roberto Luksch (285571)

February 2013

Progression Free Survival (PFS) according to stage (localized or metastatic disease).</p

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.001).

Vicenilma de Andrade Martins (5851469)
Jaqueline Diniz Pinho (5851472)
Antonio Augusto Lima Teixeira Júnior (5851475)
Leudivan Ribeiro Nogueira (5851478)
Fábio França Silva (5851481)
Victor Eduardo Maulen (5851484)
André Salim Khayat (394567)
José de Ribamar Rodrigues Calixto (5851487)
Herikson Araújo Costa (5851490)
Leandra Naira Zambelli Ramalho (162689)
Gyl Eanes Barros Silva (5100281)

October 2018

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.00...

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survival (C).

Kiyoaki Tsukahara (691531)
Akira Kubota (691532)
Yasuhisa Hasegawa (691533)
Hideki Takemura (691534)
Tomonori Terada (691535)
Takahide Taguchi (691536)
Kunihiko Nagahara (691537)
Hiroaki Nakatani (691538)
Kunitoshi Yoshino (691539)
Yuichiro Higaki (691540)
Shigemichi Iwae (691541)
Takeshi Beppu (691542)
Yutaka Hanamure (691543)
Kichinobu Tomita (691544)
Naoyuki Kohno (691545)
Kazuyoshi Kawabata (691546)
Masanori Fukushima (457544)
Satoshi Teramukai (386488)
Masato Fujii (691547)

February 2015

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survi...

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.

Taeryool Koo (797686)
Changhoon Song (728439)
Jae-Sung Kim (605888)
Kyubo Kim (311503)
Eui Kyu Chie (73314)
Sung-Bum Kang (538677)
Keun-Wook Lee (403308)
Jee Hyun Kim (77143)
Seung-Yong Jeong (414029)
Tae-You Kim (73316)

September 2015

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.</p

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.

Federica Pedica (432701)
Andrea Ruzzenente (432702)
Fabio Bagante (432703)
Paola Capelli (432704)
Ivana Cataldo (432705)
Serena Pedron (295544)
Calogero Iacono (432706)
Marco Chilosi (295554)
Aldo Scarpa (242345)
Matteo Brunelli (295531)
Anna Tomezzoli (432707)
Guido Martignoni (295553)
Alfredo Guglielmi (432708)

July 2013

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.</p

Disease-free survival of the patients by three risk groups according to the predicted risk probability.

Hye-Jin Shin (508261)
Jungnam Joo (29049)
Ji Hyun Yoon (508264)
Chong Woo Yoo (508265)
Joo-Young Kim (235999)

January 2014

Disease-free survival of the patients by three risk groups according to the predicted risk probab...

Progression-free survival A) in all, B) in patients stratified by non-responders and responders, and overall survival C) in all, D) in patients stratified by non-responders and responders.

Shih-Hsin Hsiao (106194)
H. Eugene Liu (501592)
Hsin-Lun Lee (501593)
Chii-Lan Lin (501594)
Wei-Yu Chen (316810)
Zhung-Han Wu (501595)
Sey-En Lin (382444)
Ling-Ling Chiang (501596)
Chi-Li Chung (106193)

December 2013

Progression-free survival A) in all, B) in patients stratified by non-responders and responders, ...

Progression-free survival in relation to clinical-pathological characteristics of patients.

Andrea Casadei Gardini (509580)
Laura Capelli (509585)
Paola Ulivi (11121)
Massimo Giannini (538695)
Eva Freier (538696)
Stefano Tamberi (538697)
Emanuela Scarpi (382324)
Alassandro Passardi (538698)
Wainer Zoli (11120)
Angela Ragazzini (538699)
Dino Amadori (11130)
Giovanni Luca Frassineti (16187)

March 2014

Progression-free survival in relation to clinical-pathological characteristics of patients.</p

Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.

Imran Ahmad (5655154)
Gabriela Kalna (192504)
Mohamed Ismail (349568)
Fiona Birrell (443781)
Sue Asterling (443782)
Elaine McCartney (443783)
Damien Greene (443784)
John Davies (78364)
Hing Y. Leung (152252)

August 2013

Disease free survival by (a) Pre-SCT PSA, (b) Gleason Score and (c) PSA nadir.</p

Disease-free survival by treatment (chemoradiation therapy or radiation therapy alone).

David T. Miyamoto (419629)
Akila N. Viswanathan (419630)

June 2013

Disease-free survival by treatment (chemoradiation therapy or radiation therapy alone).</p

Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group in the whole group of patients.

Peng Zhang (2071)
Mian Xi (416661)
Lei Zhao (144153)
Jing-Xian Shen (498900)
Qiao-Qiao Li (416662)
Li-Ru He (617087)
Shi-Liang Liu (498899)
Meng-Zhong Liu (416667)

August 2014

Overall survival (A) and progression-free survival (B) for the CCRT group and the RT alone group ...

Overall survival and disease-free survival of patients in the primary NACT group by the number of lymph nodes involved (A, B) and the number of lymph node groups involved (C, D).

Ting Hu (110925)
Xiong Li (112522)
Qinghua Zhang (145923)
Kecheng Huang (636531)
Yao Jia (429494)
Ru Yang (429495)
Fangxu Tang (720336)
Qiang Tian (46635)
Ding Ma (115288)
Shuang Li (146392)

April 2015

Overall survival and disease-free survival of patients in the primary NACT group by the number of...

Survival outcomes.

Yuri Jeong (781386)
Sang Min Yoon (481489)
Seungbong Han (781387)
Ju Hyun Shim (481492)
Kang Mo Kim (154235)
Young-Suk Lim (388118)
Han Chu Lee (154230)
So Yeon Kim (196803)
Jin-hong Park (481496)
Sang-wook Lee (3358886)
Seung Do Ahn (781388)
Eun Kyung Choi (781389)
Jong Hoon Kim (481497)

August 2015

Overall survival rates (A) and progression-free survival rates (B) in all patients.</p

A. Disease-free survival according to treatment group. Fig 1A shows Kaplan Meier’s disease-free survival curves according to treatment group. B. Disease-free survival according to stage. Fig 1B shows Kaplan Meier’s disease-free survival curves according to stage; the analysis was performed on 301 patients, since data on stage were missing for 2 patients.

Stefania Gori (591005)
Alessandro Inno (792326)
Elena Fiorio (792327)
Jennifer Foglietta (792328)
Antonella Ferro (792329)
Marcella Gulisano (792330)
Graziella Pinotti (792331)
Marta Gubiotti (792332)
Maria Giovanna Cavazzini (792333)
Monica Turazza (792334)
Simona Duranti (792335)
Valeria De Simone (792336)
Laura Iezzi (792337)
Giancarlo Bisagni (792338)
Simon Spazzapan (792339)
Luigi Cavanna (780317)
Chiara Saggia (792340)
Emilio Bria (295532)
Elisabetta Cretella (792341)
Patrizia Vici (85361)
Daniele Santini (222870)
Alessandra Fabi (85359)
Ornella Garrone (792342)
Antonio Frassoldati (792343)
Laura Amaducci (792344)
Silvana Saracchini (792345)
Lucia Evangelisti (792346)
Sandro Barni (477365)
Teresa Gamucci (477362)
Lucia Mentuccia (792347)
Lucio Laudadio (792348)
Alessandra Zoboli (792349)
Fabiana Marchetti (792350)
Giuseppe Bogina (792351)
Gianluigi Lunardi (792352)
Luca Boni (102949)

September 2015

A. Disease-free survival according to treatment group. Fig 1A shows Kaplan Meier’s disease-free s...

Overall survival and disease-free survival according to cut-off value 3 of pre-NLR (A, B) and post-NLR (C, D).

Yoon Jin Cha (603666)
Eun Jung Park (257700)
Seung Hyuk Baik (6078800)
Kang Young Lee (4524670)
Jeonghyun Kang (6078797)

March 2019

Overall survival and disease-free survival according to cut-off value 3 of pre-NLR (A, B) and post-N...

Progression Free Survival (PFS) according to stage (localized or metastatic disease).

Maria Antonietta De Ioris (285547)
Arcangelo Prete (285549)
Raffaele Cozza (285551)
Marta Podda (285554)
Carla Manzitti (285556)
Andrea Pession (229860)
Elisabetta Schiavello (285558)
Benedetta Contoli (285560)
Rita Balter (104350)
Franca Fagioli (285563)
Gianni Bisogno (285565)
Loredana Amoroso (285567)
Franco Locatelli (130400)
Roberto Luksch (285571)

February 2013

Progression Free Survival (PFS) according to stage (localized or metastatic disease).</p

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.001).

Vicenilma de Andrade Martins (5851469)
Jaqueline Diniz Pinho (5851472)
Antonio Augusto Lima Teixeira Júnior (5851475)
Leudivan Ribeiro Nogueira (5851478)
Fábio França Silva (5851481)
Victor Eduardo Maulen (5851484)
André Salim Khayat (394567)
José de Ribamar Rodrigues Calixto (5851487)
Herikson Araújo Costa (5851490)
Leandra Naira Zambelli Ramalho (162689)
Gyl Eanes Barros Silva (5100281)

October 2018

Disease-free survival analysis of HPV+ patients (N = 49) compared to HPV- patients (log-rank p< 0.00...

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survival (C).

Kiyoaki Tsukahara (691531)
Akira Kubota (691532)
Yasuhisa Hasegawa (691533)
Hideki Takemura (691534)
Tomonori Terada (691535)
Takahide Taguchi (691536)
Kunihiko Nagahara (691537)
Hiroaki Nakatani (691538)
Kunitoshi Yoshino (691539)
Yuichiro Higaki (691540)
Shigemichi Iwae (691541)
Takeshi Beppu (691542)
Yutaka Hanamure (691543)
Kichinobu Tomita (691544)
Naoyuki Kohno (691545)
Kazuyoshi Kawabata (691546)
Masanori Fukushima (457544)
Satoshi Teramukai (386488)
Masato Fujii (691547)

February 2015

Kaplan-Meier estimates of disease-free survival (A), relapse-free survival (B), and overall survi...

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.

Taeryool Koo (797686)
Changhoon Song (728439)
Jae-Sung Kim (605888)
Kyubo Kim (311503)
Eui Kyu Chie (73314)
Sung-Bum Kang (538677)
Keun-Wook Lee (403308)
Jee Hyun Kim (77143)
Seung-Yong Jeong (414029)
Tae-You Kim (73316)

September 2015

Kaplan-Meier curves for (A) overall survival and (B) disease-free survival for all patients.</p

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.

Federica Pedica (432701)
Andrea Ruzzenente (432702)
Fabio Bagante (432703)
Paola Capelli (432704)
Ivana Cataldo (432705)
Serena Pedron (295544)
Calogero Iacono (432706)
Marco Chilosi (295554)
Aldo Scarpa (242345)
Matteo Brunelli (295531)
Anna Tomezzoli (432707)
Guido Martignoni (295553)
Alfredo Guglielmi (432708)

July 2013

Disease free survival (DFS) of c-myc disomic, polysomic and amplified groups.</p

Disease-free survival (A) in all patients (N = 184) and (B) according to stages.

Abstract

Extracted data

Disease-free survival (A) in all patients (N = 184) and (B) according to stages.

Abstract

Extracted data

Related items

Related items